Point-of-Care Testing

News on technologies and applications for point-of-care testing.

Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'

Premium

Quidel expects to launch at least four new products over the next year and commented on its overall COVID-19 strategy, as well as R&D plans, M&A possibilities, and other updates.

Credo Diagnostics Combo Influenza, COVID-19 Test Receives CE-IVD Mark

The point-of-care test runs on the VitaPCR instrument and delivers results in 20 minutes, and has been implemented at Charles De Gaulle airport.

Quidel Q3 Revenues Nearly Triple, Beat Analyst Expectations

The firm reported $57.8 million in revenues for its Lyra SARS-CoV-2 molecular diagnostic assays in the quarter.

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

The funding is part of a BARDA contract worth up to $72 million to support the development of a test to diagnose acute infection at the point of care.

Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes

Premium

The company's CEO said that its single-molecule tethering technology has demonstrated limits of detection comparable to commercial molecular tests.

Oct 14, 2020

Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching

Oct 13, 2020

Cue Health Receives $481M From DoD to Expand COVID-19 Testing Capacity

Oct 13, 2020

SomaLogic, Academic Collaborators Win $1M NSF Grant to Develop Proteomic Screening Assay

Oct 12, 2020

Spectrum Solutions Saliva Collection Device, Access Bio, Genalyte Coronavirus Tests Get FDA EUAs

Oct 09, 2020

India Banks on Decentralized Molecular COVID-19 Testing

Premium

Oct 08, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Premium

Oct 07, 2020

Prenatal Diagnosis Society Recommends cfDNA Screening for Autosomal Trisomies in Twin Pregnancies

Oct 07, 2020

DnaNudge Signs Manufacturing Deal for Coronavirus Test Component With Jabil Healthcare

Oct 07, 2020

Abbott ID Now Study Data Confirms Test Sensitivity and Specificity

Oct 06, 2020

RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing

Oct 06, 2020

BioFire Diagnostics, UMass Medical Coronavirus Tests Get FDA Emergency Use Authorization

Oct 01, 2020

Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Sep 29, 2020

FDA Grants Emergency Use Authorization for Genetrack Biolabs SARS-CoV-2 Molecular Assay

Sep 25, 2020

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

Sep 25, 2020

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

Sep 21, 2020

Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection

Premium

Sep 21, 2020

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Sep 16, 2020

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Sep 15, 2020

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

Sep 11, 2020

Ultra-Cheap, Sensitive DNA Nanoswitch Tech Developed for SARS-CoV-2 Detection

Premium

Breaking News

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

Featured White Papers

Improving POC Device Manufacturability – 5 Expert Approaches

Best Practices for Point of Care (POC) Product Development

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Nov

10

Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Menu

Point-of-Care Testing

What's Popular?